Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Intravenous Unfractionated Heparin Starting Infusion Rate for Adult Patients With Deep Vein Thrombosis/Pulmonary Embolism or Cardiac Indications

NCT07250763 is registered in ClinicalTrials.gov with Inova Health Care Services as lead sponsor.

NCT NCT07250763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07250763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Intravenous Unfractionated Heparin Starting Infusion Rate for Adult Patients With Deep Vein Thrombosis/Pulmonary Embolism or Cardiac Indications
Lead sponsor
Inova Health Care Services
Phase
Phase 4
Overall status
Active, not recruiting
Start date
September 20, 2023
Completion date
May 31, 2027
Enrollment
145 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute cardiac syndrome, atrial fibrillation, deep vein thrombosis, mechanical heart valve recipients, pulmonary embolism